Careful with that cautionary stuff, Umibe5690. They don't like that around here, not one bit. It's way more relevant to post rumors found on penny-stock Twitter pump accounts, and relay anecdotes about how a doctor friend once thought DCVax could never work, but now he works for a BP and is all-in on NWBO. That's the real world to some folks. Never mind facts. Never mind that we literally have been hearing the same claims about data lock, unblinding, and big pharma buyouts for years! Yes years, and never once have these prognostications been correct. Not once. But now it's different, and glory days are imminent.
After being told that August was the month, and then that October was the month, we were told repeatedly that November had to be the month. We were told the company had no choice but to unblind in November.
We were told that they were out of money and wouldn't be able to sustain operations, and that there was simply no benefit in keeping this trial going any further, so November had to be the month. We were told they already were well into the "processes" that Linda laid out in her press release (the same processes she now says haven't even begun). We were told that everything lined up for a submission to NICE with approval imminent. We were even shown the documents to prove that the NICE submission was under way! Funny how quickly the NICE bandwagon of misinformation was abandoned.
Finally, we were told that if nothing happened in November, there would be shareholder revolt and the stock price would plummet to single pennies. But that didn't happen. In fact, nothing happened, just like nothing we are told regarding NWBO ever happens. Yeah, I know, there was more of that blinded, blended, interim data presented by the company's lead researcher. Some people think that blinded, blended, incomplete data is as good as FDA approval. I don't think so, and neither does the market. Meanwhile, the only thing we've heard from the company is an incredibly vague and half-hearted statement following the release of this interim data that yes, it may be time to start the process of unblinding – soon, we think – and it probably will take another year before we have anything that we could even hypothetically consider presenting to the FDA. Oh, and they also released a fake delayed 10-Q announcement intended to convince everyone a deal is imminent.
It worked, and the charade continues, on and on and on.
Yeah, I know, this time it's different. I'll see. They'll show me and all the other shorts! Ok, but I'm not a short. I'm a long and I don't believe a g-dam word this company says – ever. They are enriching themselves at our expense, and it is wrong.
News 
Market Data 
Discover 
AI
